1. Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study. Issue 6 (30th July 2014) Authors: Hézode, Christophe; Hirschfield, Gideon M; Ghesquiere, Wayne; Sievert, William; Rodriguez-Torres, Maribel; Shafran, Stephen D; Thuluvath, Paul J; Tatum, Harvey A; Waked, Imam; Esmat, Gamal; Lawitz, Eric J; Rustgi, Vinod K; Pol, Stanislas; Weis, Nina; Pockros, Paul J; Bourlière, Marc; Serfaty, Law... Journal: Gut Issue: Volume 64:Issue 6(2015) Page Start: 948 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Daclatasvir/asunaprevir/beclabuvir, all‐oral, fixed‐dose combination for patients with chronic hepatitis C virus genotype 1. Issue 12 (10th November 2017) Authors: Kao, Jia‐Horng; Yu, Ming‐Lung; Peng, Cheng‐Yuan; Heo, Jeong; Chu, Chi‐Jen; Chang, Ting‐Tsung; Lee, Youn‐Jae; Hu, Tsung‐Hui; Yoon, Ki Tae; Paik, Seung Woon; Lim, Young Suk; Ahn, Sang Hoon; Isakov, Vasily; McPhee, Fiona; Hu, Wenhua; Scott Swenson, Eugene; Yin, Philip D; Treitel, Michelle Journal: Journal of gastroenterology and hepatology Issue: Volume 32:Issue 12(2017) Page Start: 1998 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomized Controlled Trial of the NS5A Inhibitor Daclatasvir plus Pegylated Interferon and Ribavirin for HCV Genotype-4 (COMMAND-4). Issue 3 (April 2016) Authors: Hézode, Christophe; Alric, Laurent; Brown, Ashley; Hassanein, Tarek; Rizzetto, Mario; Buti, Maria; Bourlière, Marc; Thabut, Dominique; Molina, Esther; Rustgi, Vinod; Samuel, Didier; McPhee, Fiona; Liu, Zhaohui; Yin, Philip D; Hughes, Eric; Treitel, Michelle Journal: Antiviral therapy Issue: Volume 21:Issue 3(2016) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗